Barriers to integrating direct oral anticoagulants into anticoagulation clinic care: A mixed-methods study

Geoffrey D Barnes1,2, Jennifer Acosta2, Christopher Graves1

  • 1Michigan Clinical Outcomes Research and Reporting Program University of Michigan Ann Arbor Michigan.

Abstract

Insights

Integrating direct oral anticoagulant (DOAC) care into anticoagulation clinics faces barriers related to provider awareness, finances, and clinical scope. These challenges vary by clinic size, care model, and staff expertise.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Health Services Research

Background:

  • Outpatient anticoagulation clinics traditionally manage warfarin therapy.
  • Systematic evaluations of integrating direct oral anticoagulant (DOAC) care are lacking.

Purpose of the Study:

  • To identify barriers and facilitators to incorporating direct oral anticoagulant (DOAC) care into established anticoagulation clinics.

Main Methods:

  • A mixed-methods approach combining online surveys of 159 clinics and 20 semi-structured interviews with clinic leaders.
  • Qualitative data from interviews were coded for themes, and survey data were analyzed using summary statistics.

Main Results:

  • Key barriers included limited provider awareness of clinic services, financial constraints, and scope-of-practice concerns among staff.
  • Barriers were associated with clinic size, hospital affiliation, care delivery method (in-person vs. telephone), and staff composition (nurses vs. pharmacists).

Conclusions:

  • US anticoagulation clinics face significant obstacles in adopting direct oral anticoagulant (DOAC) management.
  • Barriers are influenced by clinic characteristics, existing warfarin care models, and the professional background of the clinical staff.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.9K
Velocity and Position by Integral Method01:13

Velocity and Position by Integral Method

If acceleration as a function of time is known, then velocity and position functions can be derived using integral calculus. For constant acceleration, the integral equations refer to the first and second kinematic equations for velocity and position functions, respectively.
Consider an example to calculate the velocity and position from the acceleration function. A motorboat is traveling at a constant velocity of 5.0 m/s when it starts to decelerate to arrive at the dock. Its acceleration is...
7.8K
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
220
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
437
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
341